Company
Headquarters: Toronto, ON, Canada
CEO: Mr. Ronald C. Loucks
C$16.6 Million
CAD as of Jan. 1, 2024
US$12.5 Million
Company | Market Cap (USD) |
---|---|
UnitedHealth Group | $504.47 B |
Elevance Health | $113.92 B |
CVS Health | $104.08 B |
Cigna Corporation | $89.61 B |
Humana Inc. | $57.44 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
NexgenRx, Inc. has the following listings and related stock indices.
Stock: TSXV: NXG wb_incandescent
Stock: OTC: NEGXF wb_incandescent